Wealthcare Advisory Partners LLC Plus Therapeutics, Inc. Transaction History

Wealthcare Advisory Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.0 - $2.89 $2 - $2	-1 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.1 - $3.75 $2 - $3	1 New	1 $0
Q2 2020 Jul 29, 2020	SELL	$1.43 - $2.33 $1 - $2	-1 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$3.3 - $19.25 $3 - $19	1 New	1 $0

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $40M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.